After TAVI, anticoagulants outperform antiplatelet agents at preventing clots

After transcatheter aortic valve implantation (TAVI), anticoagulation reduced imaging signs of clot enactment connected the caller valve compared with antiplatelet therapy, without compromising safety. This was the main uncovering of the ACASA-TAVI proceedings presented successful a Hot Line league astatine ESC Congress 2026 and published simultaneously successful JAMA.